WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...

The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

Total solar eclipses are not just incredible celestial events. They are also important scientific moments that allow ...

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

Researchers have provided more evidence that mpox virus can be passed from a pregnant mother to her child. There remain ...

The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Immuno Cure Biotech Ltd. is collaborating with Pharmajet Inc. to evaluate the safety and immunogenicity of its HIV ...